公司资料
Petros Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- PTPI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
As of Aug 17, 2026, PTPI was little changed and closed at $0.0027. No new same-company headline was identified in the current news window.
公司概览
业务概览
Petros Pharmaceuticals is a specialty pharmaceutical company focused on men’s health and self-care products, including sexual-health-related therapies. Its business is centered on consumer-accessible specialty medicines rather than classic biotech discovery.
所在地与行业分类
Petros is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and men’s health.
商业模式特征
The company depends on commercial execution, regulatory pathways, and the ability to expand access to a narrow product set. Investors usually watch product adoption, label strategy, and cash management.
生物医药行业定位
Petros occupies a niche men’s-health specialty-pharma position. It is less about clinical-stage binary risk and more about commercial access and brand execution.
未来催化剂
- Petros’s catalysts are men’s-health and sexual-health commercialization, plus any strategic update that clarifies the company’s future. The market will care about whether the product base can stabilize.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。